Glenmark Life Sciences Ltd Q1FY23 PAT up QoQ at Rs. 108.73 crores

Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 499.363 crores during the period ended June 30, 2022 as compared to Rs. 519.152 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 108.733 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 98.897 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 8.87 for the period ended June 30, 2022 as compared to Rs. 8.07 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 499.363 crs	₹519.152 crs	-3.81%
Net Profit	₹108.733 crs	₹98.897 crs	9.95%
EPS	₹8.87	₹8.07	9.91%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 499.363 crores during the period ended June 30, 2022 as compared to Rs.528.883 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.108.733 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.100.913 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.8.87 for the period ended June 30, 2022 as compared to Rs.9.36 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 499.363 crs	₹528.883 crs	-5.58%
Net Profit	₹108.733 crs	₹100.913 crs	7.75%
EPS	₹8.87	₹9.36	-5.24%

Shares of Glenmark Life Sciences Ltd was last trading in BSE at Rs. 448.90 as compared to the previous close of Rs. 455.65. The total number of shares traded during the day was 12308 in over 1489 trades.

The stock hit an intraday high of Rs. 460.00 and intraday low of 448.00. The net turnover during the day was Rs. 5557778.00.

Source : Equity Bulls

Keywords

GlenmarkLifeSciences Q1FY23 ResultUpdate